Review
Published on 20 May 2022
Prevention and Treatment of Side Effects of Immunotherapy for Bladder Cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.879391
- 5,678 views
- 9 citations
Type at least 3 characters
1,561 articles
Articles
Review
Published on 20 May 2022
Liquid Biopsy Based Circulating Biomarkers in Metastatic Prostate Cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.863472
- 5,903 views
- 14 citations
Original Research
Published on 20 May 2022
Transcriptome Profiles Reveal a 12-Signature Metabolic Prediction Model and a Novel Role of Myo-Inositol Oxygenase in the Progression of Prostate Cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.899861
- 2,006 views
- 1 citation
Original Research
Published on 20 May 2022
Identification of Novel Pyroptosis-Related Gene Signatures to Predict Prostate Cancer Recurrence
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.814912
- 2,617 views
- 4 citations
Case Report
Published on 20 May 2022
Case Report: New Onset Lymphadenopathy After Immune Checkpoint Inhibitor Therapy Presents a Clinicopathological and Radiological Challenge
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.876797
- 3,697 views
- 2 citations
Original Research
Published on 19 May 2022
A Novel Combination of Serum Markers in a Multivariate Model to Help Triage Patients Into “Low-” and “High-Risk” Categories for Prostate Cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.837127
- 2,773 views
- 7 citations
Original Research
Published on 19 May 2022
Real-World Therapy Management and Outcomes of First-Line Axitinib Plus Pembrolizumab in Patients With Advanced Renal Cell Carcinoma in the United States
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.861189
- 3,523 views
- 9 citations
Case Report
Published on 19 May 2022
Concurrent Germline and Somatic Mutations in FLCN and Preliminary Exploration of Its Function: A Case Report
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.877470
- 2,570 views
- 1 citation
Original Research
Published on 18 May 2022
Could We Safely Avoid a Second Resection in Selected Patients With T1 Non-Muscle-Invasive Bladder Cancer? Preliminary Results of Cost-Effectiveness Study From HUmanitas New Indications for ReTUR (HuNIRe) Multicenter Prospective Trial
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.879399
- 1,730 views
- 5 citations
Original Research
Published on 17 May 2022
Oligoprogression in Metastatic, Castrate-Resistant Prostate Cancer—Prevalence and Current Clinical Practice
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.862995
- 4,120 views
- 6 citations
Systematic Review
Published on 16 May 2022
Prognostic Significance of Pretreatment Neutrophil-to-Lymphocyte Ratio, Platelet−to−Lymphocyte Ratio, or Monocyte-to-Lymphocyte Ratio in Endometrial Neoplasms: A Systematic Review and Meta−analysis
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.734948
- 4,171 views
- 23 citations
Original Research
Published on 16 May 2022
Comprehensive Genomic Characterization of Tumor Microenvironment and Relevant Signature in Clear Cell Renal Cell Carcinoma
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.749119
- 3,153 views
- 1 citation
Review
Published on 13 May 2022
Non-Coding RNA in Penile Cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.812008
- 2,930 views
- 2 citations
Editorial
Published on 13 May 2022
Editorial: Metastatic Castration Resistant Prostate Cancer: Prognosis and Treatment
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.913630
- 6,549 views
- 4 citations
Case Report
Published on 12 May 2022
Giant Polycystic Papillary Renal Cell Carcinoma: A Case Report and Literature Review
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.876217
- 1,909 views
- 3 citations
Original Research
Published on 12 May 2022
Survival of Patients With UrAC and Primary BAC and Urothelial Carcinoma With Glandular Differentiation
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.860133
- 1,759 views
- 3 citations